The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction
- 1 September 2019
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 215, 62-69
Abstract
No abstract availableKeywords
Funding Information
- Royal Perth Hospital Medical Research Foundation
- National Heart Foundation of Australia
This publication has 20 references indexed in Scilit:
- Colchicine and the HeartJACC, 2013
- Mechanisms of Acute Coronary Syndromes and Their Implications for TherapyNew England Journal of Medicine, 2013
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular DiseaseJACC, 2013
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)American Heart Journal, 2011
- Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trialJournal of Thrombosis and Thrombolysis, 2011
- Colchicine for pericarditis: hype or hope?European Heart Journal, 2009
- Effect of Colchicine (0.5 mg Twice Daily) on High-Sensitivity C-Reactive Protein Independent of Aspirin and Atorvastatin in Patients With Stable Coronary Artery DiseaseThe American Journal of Cardiology, 2007
- C-Reactive Protein Levels and Outcomes after Statin TherapyNew England Journal of Medicine, 2005
- Inflammation and AtherosclerosisCirculation, 2002
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999